title: Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation.
authors.forename: W
authors.initials: W
authors.lastname: Zhidong
authors.forename: Y
authors.initials: Y
authors.lastname: Hongmin
authors.forename: W
authors.initials: W
authors.lastname: Hengxiang
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001787:Blood Group Incompatibility / Q000150:complications*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D012010:Red-Cell Aplasia, Pure / Q000178:diet therapy* / Q000209:etiology*; D000069283:Rituximab; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab